Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival.

An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg (1999) 4.26

Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J (2010) 2.57

Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg (2003) 2.01

Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus. World J Gastroenterol (2006) 1.89

Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto. Gut (2002) 1.66

Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg (2001) 1.58

Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients. Br J Cancer (2005) 1.51

Hepatocellular carcinoma in Central Europe: prognostic features and survival. Gut (2001) 1.45

A Collision Probability Model of Portal Vein Tumor Thrombus Formation in Hepatocellular Carcinoma. PLoS One (2015) 1.39

Wnt signaling in liver cancer. Curr Drug Targets (2008) 1.34

Review of 336 patients with hepatocellular carcinoma at Songklanagarind Hospital. World J Gastroenterol (2000) 1.14

Comparison of coplanar and noncoplanar intensity-modulated radiation therapy and helical tomotherapy for hepatocellular carcinoma. Radiat Oncol (2010) 1.12

Meta-analysis: underutilisation and disparities of treatment among patients with hepatocellular carcinoma in the United States. Aliment Pharmacol Ther (2013) 1.11

Surveillance for hepatocellular carcinoma improves survival in Asian-American patients with hepatitis B: results from a community-based clinic. Dig Dis Sci (2009) 1.09

Clinicopathological characteristics of alpha-fetoprotein-producing gastric cancer. J Gastric Cancer (2011) 1.03

Prognostic factors for portal venous invasion in patients with hepatocellular carcinoma. J Gastroenterol (2007) 1.01

Highly metabolic thrombus of the portal vein: 18F fluorodeoxyglucose positron emission tomography/computer tomography demonstration and clinical significance in hepatocellular carcinoma. World J Gastroenterol (2008) 1.01

Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival. J Gastroenterol (2008) 1.01

Radiofrequency ablation of hepatocellular carcinoma: pros and cons. Gut Liver (2010) 0.98

Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma. Thromb Res (2007) 0.98

Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation. Can J Gastroenterol (2007) 0.97

Hypofractionated radiotheapy using helical tomotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis. Radiat Oncol (2013) 0.96

Clinical presentation of hepatocellular carcinoma (HCC) in Asian-Americans versus non-Asian-Americans. J Immigr Minor Health (2011) 0.93

High incidence of hepatitis B infection-associated cirrhosis and hepatocellular carcinoma in the Southeast Asian patients with portal vein thrombosis. BMC Gastroenterol (2011) 0.92

Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS. Liver Int (2014) 0.91

Current status of radiofrequency ablation of hepatocellular carcinoma. World J Gastrointest Surg (2010) 0.91

Radiation therapy for portal venous invasion by hepatocellular carcinoma. World J Gastroenterol (2005) 0.89

Characteristic analysis of α-fetoprotein-producing gastric carcinoma in China. World J Surg Oncol (2013) 0.88

Epidemiology and survival of patients with hepatocellular carcinoma in Southern Germany. Int J Clin Exp Med (2010) 0.86

Positron emission tomography of human hepatocellular carcinoma xenografts in mice using copper (II)-64 chloride as a tracer with copper (II)-64 chloride. Acad Radiol (2011) 0.86

Indications for referral and assessment in adult liver transplantation: a clinical guideline. British Society of Gastroenterology. Gut (1999) 0.85

Analysis of prognostic factors and 5-year survival rate in patients with hepatocellular carcinoma: a single-center experience. Korean J Hepatol (2012) 0.85

The antitumor effect and hepatotoxicity of a hexokinase II inhibitor 3-bromopyruvate: in vivo investigation of intraarterial administration in a rabbit VX2 hepatoma model. Korean J Radiol (2009) 0.85

In vivo assessment of angioarchitecture and microcirculation in experimental liver cancer: a new model in rats. Dig Dis Sci (2003) 0.85

Practical effect of sorafenib monotherapy on advanced hepatocellular carcinoma and portal vein tumor thrombosis. Gut Liver (2013) 0.83

Molecular determinants of outcome in sorafenib-treated patients with hepatocellular carcinoma. J Cancer Res Clin Oncol (2013) 0.83

Transcatheter arterial chemoembolization combined with radiofrequency ablation delays tumor progression and prolongs overall survival in patients with intermediate (BCLC B) hepatocellular carcinoma. BMC Cancer (2014) 0.83

Radiofrequency ablation following first-line transarterial chemoembolization for patients with unresectable hepatocellular carcinoma beyond the Milan criteria. BMC Gastroenterol (2014) 0.82

Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation. World J Gastroenterol (2013) 0.81

Are metastases from metastases clinical relevant? Computer modelling of cancer spread in a case of hepatocellular carcinoma. PLoS One (2012) 0.80

Sorafenib versus cytotoxic chemotherapy for patients with advanced hepatocellular carcinoma: a retrospective, single-institution study. Invest New Drugs (2011) 0.80

A new model to estimate prognosis in patients with hepatocellular carcinoma after Yttrium-90 radioembolization. PLoS One (2013) 0.80

The response of thrombosis in the portal vein or hepatic vein in hepatocellular carcinoma to radiation therapy. Radiat Oncol J (2016) 0.79

The effectiveness of particle radiotherapy for hepatocellular carcinoma associated with inferior vena cava tumor thrombus. J Gastroenterol (2011) 0.79

Impact of preoperative α-fetoprotein level on disease-free survival after liver transplantation for hepatocellular carcinoma. World J Surg (2012) 0.78

Adjuvant percutaneous radiofrequency ablation of feeding artery of hepatocellular carcinoma before treatment. World J Gastroenterol (2009) 0.78

Metastatic hepatocellular carcinoma presenting as facial nerve palsy and facial pain. Korean J Hepatol (2011) 0.77

Predictors of alcohol use among rural drug users after disclosure of hepatitis C virus status. J Stud Alcohol Drugs (2013) 0.77

Complete Metabolic Response with Recanalization of Portal Vein Tumor Thrombosis after Sunitinib in a Patient with Advanced Hepatocellular Carcinoma. Case Rep Oncol (2010) 0.76

Refusal of cancer-directed surgery strongly impairs survival of patients with localized hepatocellular carcinoma. Int J Surg Oncol (2010) 0.76

Rupture of hepatocellular carcinoma into the biliary system with resulting bile duct thrombi: report of two cases. Case Rep Gastroenterol (2007) 0.75

Emergency endoscopic variceal ligation following variceal rupture in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis: a retrospective study. World J Surg Oncol (2016) 0.75

Liver transplantation for hepatocellular carcinoma in Ireland: Pre-operative alpha-fetoprotein predicts tumour recurrence in a 14-year single-centre national experience. World J Transplant (2016) 0.75

Radiofrequency ablation of hepatocellular carcinoma extended into the portal vein: Preliminary results. J Ultrasound (2009) 0.75

Hepatocellular Carcinoma Without Cirrhosis Presenting With Hypercalcemia: Case Report and Literature Review. J Clin Exp Hepatol (2015) 0.75

Diagnosis of hepatoma using grayscale and Doppler ultrasound in patients with chronic liver disease. Int J Gen Med (2011) 0.75

The optimal follow-up period in patients with above 5-year disease-free survival after curative liver resection for hepatocellular carcinoma. J Korean Surg Soc (2013) 0.75

Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Arch Surg (1992) 2.10

Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg (1998) 2.10

Aggressive surgical resection for cholangiocarcinoma. Arch Surg (1995) 1.80

Procurement of a whole pancreas and liver from the same cadaveric donor. Surgery (1989) 1.49

Surgical management of nonparasitic cystic liver disease. Am J Surg (1991) 1.45

Surgical treatment of biliary cystadenoma. A report of 15 cases. Arch Surg (1988) 1.43

Epilepsy and craniofacial abnormalities. J Assoc Physicians India (1991) 1.39

Resting energy expenditure in patients with end-stage liver disease and in normal population. JPEN J Parenter Enteral Nutr (1987) 1.38

Hepatic transplantation survival: correlation with adenine nucleotide level in donor liver. Hepatology (1988) 1.32

The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. Hepatology (1997) 1.29

Fibrinolysis during liver transplantation in humans: role of tissue-type plasminogen activator. Blood (1988) 1.22

The high-risk liver allograft recipient. Should allocation policy consider outcome? Arch Surg (1992) 1.22

Cavernous hemangioma of the liver: anatomic resection vs. enucleation. Arch Surg (1999) 1.15

Live donor adult liver transplantation using right lobe grafts: donor evaluation and surgical outcome. Arch Surg (2001) 1.13

Liver transplantation for primary hepatic cancer. Transplantation (1992) 1.13

Psychiatric syndromes in children and their relation to family background. Am J Orthopsychiatry (1966) 1.08

A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection. Transplantation (1987) 1.07

Surgical therapy for recurrent liver metastases from colorectal cancer. Arch Surg (1990) 1.06

The direct-injection GLC analysis of xylenols in industrial wastewaters. Bull Environ Contam Toxicol (1977) 1.06

Improved survival after live donor adult liver transplantation (LDALT) using right lobe grafts: program experience and lessons learned. Am J Transplant (2006) 1.06

Risk factors for invasive fungal infections complicating orthotopic liver transplantation. J Infect Dis (1994) 1.05

A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection. Transplant Proc (1987) 1.03

Retroversus implantation of a liver graft: a novel approach to the deceased donor with situs inversus totalis. Am J Transplant (2007) 1.03

Role of staging laparoscopy in the treatment of hepatic malignancy. Am J Surg (1994) 1.01

Ganciclovir therapy of severe cytomegalovirus infections in solid-organ transplant recipients. Transplantation (1988) 1.01

A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma. Cancer (1998) 1.00

Hepatic cryosurgery with intraoperative ultrasound monitoring for metastatic colon carcinoma. Arch Surg (1987) 0.98

The acquired immunodeficiency syndrome and transplantation. Transplantation (1987) 0.95

Liver masses: replacement of conventional T2-weighted spin-echo MR imaging with breath-hold MR imaging. Radiology (1996) 0.95

Multimodality treatment of hepatocellular carcinoma in a hepatobiliary specialty center. Arch Surg (1996) 0.94

Biliary tract complications after liver transplantation. Arch Surg (1995) 0.93

Liver transplantation for autoimmune hepatitis: a long-term pathologic study. Hepatology (2000) 0.92

Graft function and outcome of older (> or = 60 years) donor livers. Transplantation (1996) 0.92

Herbal toxicity and fatal hepatic failure. Am J Med (1999) 0.92

Imaging of the portal venous system in patients with cirrhosis: MR angiography vs duplex Doppler sonography. AJR Am J Roentgenol (1993) 0.91

Combined liver-kidney transplantation in patients with cirrhosis and renal failure: effect of a positive cross-match and benefits of combined transplantation. Liver Transpl Surg (1998) 0.90

Gilles de la Tourette's syndrome in identical twins. Arch Neurol (1983) 0.90

Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy. Transplantation (1998) 0.90

Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression. Transplantation (1995) 0.90

Surgical aspects of sclerosing cholangitis. Results in 178 patients. Ann Surg (1990) 0.88

Acute hepatic failure associated with oral minocycline: a case report. Pharmacotherapy (1992) 0.88

Recovery of visual-spatial learning and memory in chronic alcoholics. J Clin Psychol (1981) 0.86

Survival from hepatic transplantation. Relationship of protein synthesis to histological abnormalities in patient selection and postoperative management. Ann Surg (1986) 0.86

Recurrent hepatitis B, hepatitis C, and combined hepatitis B and C in liver allografts: a comparative pathological study. Hum Pathol (2000) 0.86

Liver transplantation: MR angiography with surgical validation. Radiology (1991) 0.86

Treatment of giant hemangiomas of the liver by enucleation. J Am Coll Surg (1994) 0.85

Nutrition in patients undergoing orthotopic liver transplant. JPEN J Parenter Enteral Nutr (1986) 0.85

Primary malignant melanoma of the biliary tract. Liver Transpl Surg (1995) 0.85

Severe ascites: efficacy of the transjugular intrahepatic portosystemic shunt in treatment. Radiology (1996) 0.85

A comparison of operation, endoscopic retrograde cholangiopancreatography, and percutaneous transhepatic cholangiography in biliary complications after hepatic transplantation. J Am Coll Surg (1994) 0.85

Nifedipine interaction with tacrolimus in liver transplant recipients. Ann Pharmacother (1997) 0.84

Transfer of congenital factor XI deficiency from a donor to a recipient by liver transplantation. N Engl J Med (1987) 0.84

The Boston Center for Liver Transplantation (BCLT). Initial experience of a new surgical consortium. Arch Surg (1986) 0.84

L-[1-(13)C] Phenylalanine oxidation as a measure of hepatocyte functional capacity in end-stage liver disease. Am J Surg (1997) 0.84

Liver transplantation for adult polycystic liver disease. Liver Transpl Surg (1996) 0.84

Juvenile delinquents revisited. Adult criminal activity. Arch Gen Psychiatry (1980) 0.83

Liver transplantation. Surg Clin North Am (1985) 0.83

Whole body leucine, phenylalanine, and tyrosine kinetics in end-stage liver disease before and after hepatic transplantation. Metabolism (1987) 0.83

Effectiveness of orthotopic liver transplantation on the restoration of cholesterol metabolism in patients with end-stage liver disease. Gastroenterology (1987) 0.83

The runaway reaction. A case study. J Am Acad Child Psychiatry (1972) 0.82

Isolation and long-term culture of human hepatocytes. Surgery (1993) 0.82

The runaway reaction. Am J Psychiatry (1971) 0.82

Sarcoidosis with selective involvement of a second liver allograft: report of a case and review of the literature. Mod Pathol (1999) 0.82

HTLV-III/LAV infection in kidney and liver transplantation. Transplant Proc (1987) 0.82

Biliary intervention by means of percutaneous puncture of the antecolic jejunal loop. Radiology (1995) 0.82

Increased protein catabolism without hypermetabolism after human orthotopic liver transplantation. Surgery (1987) 0.82

Abnormal phenylalanine hydroxylation and tyrosine oxidation in a patient with acute fulminant liver disease with correction by liver transplantation. Gastroenterology (1985) 0.81

Giant neural systems in the inner retina and optic nerve of small whales. J Comp Neurol (1982) 0.81

Tourette's disease: control of symptoms and its clinical course. Int J Neuropsychiatry (1967) 0.81

Pulmonary complications of orthotopic liver transplantation. Transplantation (1986) 0.80

Serologic and DNA follow-up data from HBsAg-positive patients treated with orthotopic liver transplantation. Transplantation (1991) 0.80

FK 506 rescue therapy in liver transplant recipients with drug-resistant rejection. Transplant Proc (1991) 0.80

Fungal infections complicating orthotopic liver transplantation. Trans Am Clin Climatol Assoc (1995) 0.80

Liver transplantation in the adult. Transplant Rev (Orlando) (1987) 0.80

Orthotopic liver transplantation for familial amyloidotic polyneuropathy. Clin Transplant (1994) 0.79

Adult-to-adult live donor liver transplantation: a short-term clinicopathologic study. Hum Pathol (2001) 0.79

Liver transplantation with incidental gallbladder carcinoma in the recipient hepatectomy. HPB Surg (1994) 0.79

Development of metabolic alkalosis after massive transfusion during orthotopic liver transplantation. Crit Care Med (1987) 0.79

Liver transplantation in children: the Boston Center experience in the first 30 months. Transplant Proc (1987) 0.79

Live donor liver transplantation. J Hepatol (2001) 0.79

A randomized clinical trial of prophylactic OKT3 monoclonal antibody in liver allograft recipients. Arch Surg (1990) 0.79

Neuropsychological effect of chronic alcoholism on tactual-spatial performance and memory in males. Alcohol Clin Exp Res (1981) 0.79

Use of magnetic resonance angiography in the pretransplant evaluation of portal vein pathology. Transplantation (1993) 0.78

Types of delinquent behavior and background factors. Int J Soc Psychiatry (1968) 0.78

Surgical approach to generalized lymphadenopathy in homosexual men. J Surg Oncol (1987) 0.78

Avoidance of transhepatic drainage prior to hepaticojejunostomy for obstruction of the biliary tract. Surg Gynecol Obstet (1987) 0.78

Living adult right lobe liver transplantation: imaging before surgery with multidetector multiphase CT. AJR Am J Roentgenol (2000) 0.78

MR angiographic guidance for transjugular intrahepatic portosystemic shunt procedures. J Magn Reson Imaging (1994) 0.78

Sequential interleukin 2 and interleukin 2 receptor levels distinguish rejection from cyclosporine toxicity in liver allograft recipients. Arch Surg (1991) 0.78

Preoperative nutrition assessment in liver transplantation. Nutrition (1993) 0.78

Cyclosporine-associated thrombotic thrombocytopenic purpura following liver transplantation--successful treatment with plasma exchange. Transplantation (1987) 0.77

The impact of intraoperative ultrasonography on surgery for liver neoplasms. J Ultrasound Med (1994) 0.77

Blood carnitine status after orthotopic liver transplantation in patients with end-stage liver disease. Am J Clin Nutr (1989) 0.77

Potential protective effects of furosemide against early renal injury in liver transplant patients receiving cyclosporine-A. Crit Care Med (1989) 0.77

The varieties of children's behavioral problems and family dynamics. Am J Psychiatry (1968) 0.77

Correlation of amino acid metabolism and liver biopsies in preoperative and postoperative patients receiving hepatic transplants. Transplant Proc (1987) 0.77

A prospective, randomized trial of abdominal wound drainage in gastric bypass surgery. Ann Surg (1987) 0.77

Predictors of intraoperative death and long-term survival in liver transplantation: a multistage analysis. Transplant Proc (1989) 0.77

Hepatitis C infection: a rare cause of fulminant hepatic failure. Am J Gastroenterol (1995) 0.77

Recovery of cognitive abilities in male alcoholics. Curr Alcohol (1979) 0.76